Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afc5d8c9ee6673323cee3e2d19bc5146 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
1999-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd62ec7ce9784fa0625d8bf302aaf43b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_920f50c7c3e0ddd800e1466228ac676a |
publicationDate |
2000-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0035424-A1 |
titleOfInvention |
Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals |
abstract |
The invention relates to a substrate coating for the electrostatic deposition of dry powder medicaments for use in the manufacture of pharmaceutical dosage forms comprising micronized polyethylene glycol (PEG), with a molecular weight in the range of 1,000 to 20,000, and having a particle size of 1 - 100 νm. The invention also relates to pharmaceutical compositions having such a substrate coating, and processes for manufacturing such pharmaceutical compositions. The invention also relates to the technology of reversing negative charge of medicaments so that they can be electrostatically deposited on a negatively charged substrate. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105725128-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7030151-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0211803-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100435879-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2001282743-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107912-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20030726-B1 |
priorityDate |
1998-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |